BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Citi Maintains Buy on Aurobindo Pharma
Citi has maintained 'buy' call on Aurobindo Pharma for target price of Rs 1,120 per share. Citi says revenues could ramp up meaningfully over next few years and maintains Aurobindo as their top pick.